Prostate News Archive
07-Apr-2009
Global Prostate Cancer Therapeutics Market to Reach $4.8 Billion by 2015, According to New Report by Global Industry ... (PRWeb via Yahoo! News)
Development of new therapies and drugs for prostate cancer is likely to supplement, rather substitute the prevailing drugs or therapies, such as chemotherapy, radiation therapy, hormonal therapy and surgery, and propel sales in global prostate cancer therapeutics market to $4.8 billion by 2015. Bishop of Utah's Catholic Diocese scheduled for surgery for prostate cancer (FOX 13 Utah)
SALT LAKE CITY (AP) ? The bishop of the Catholic Diocese of Salt Lake City is scheduled to have surgery Wednesday for prostate cancer. Pre-Surgical Stress Management Improves Mood, Quality of Life for Prostate Cancer Patients (Newswise)
Brief stress management sessions prior to and immediately after surgery may have both short- and long-term benefit for men undergoing a radical prostatectomy for early-stage prostate cancer, according to research from The University of Texas M. D. Anderson Cancer Center. A potential new target for treatment of hormone refractory prostate cancer (EurekAlert!)
( Cell Press ) A new study identifies a protein that modifies the androgen receptor and influences its ability to regulate target genes linked with the progression of prostate cancer. The research, published by Cell Press in the April 7 issue of the journal Cancer Cell, may also drive creation of new strategies for the treatment of advanced prostate cancer that no longer responds to traditional ... Prostate Cancer Foundation Funds $1.0 Million in New Creativity Awards for Advanced Research (Business Wire via Yahoo! Finance)
SANTA MONICA, Calif.----The prostate Cancer Foundation today announced that it has funded ten Creativity Awards for advanced prostate cancer research. These one-year awards are designed to support innovative ideas that have the potential to achieve breakthroughs for the detection and treatment of prostate cancer.
Back to Prostate News Archive
